Last reviewed · How we verify
NCT04706650
Exercise Capacity, Cardiovascular Risk Factors and Disease-related Variables in Axial Spondyloarthritis
trial in Exercise Capacity in 76 participants. Completed in 15 October 2014.
15 October 2014
Quick facts
| Lead sponsor | Muğla Sıtkı Koçman University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 76 |
| Start date | 15 May 2014 |
| Primary completion | 15 October 2014 |
| Estimated completion | 15 October 2014 |
Conditions studied
- Exercise Capacity — all drugs for Exercise Capacity →
- Axial Spondyloarthritis — all drugs for Axial Spondyloarthritis →
Sponsor
Muğla Sıtkı Koçman University
Who can join
Adults 18 to 70, any sex, with Exercise Capacity or Axial Spondyloarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aimed to study the associations between exercise capacity and cardiovascular (CV) risk factors in axial spondyloarthritis (axSpA) patients and to determine possible relationships with disease-related variables. Thirty eight patients and 38 controls were recruited in our cross-sectional controlled study. Comprehensive systemic and musculoskeletal examinations were carried out in both of the groups. Cardiovascular risk profile data, ASDAS-CRP, 10-year CV event risk, physical activity levels (IPAQ) were recorded. A maximal treadmill exercise test by Bruce protocol was administered to all participants.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04706650
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Exercise Capacity
Currently open trials in the same condition.
- NCT06638671 — Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity · Phase 4 · recruiting
- NCT06805422 — Health-Related Physical Fitness Level From Smartwatches · active not recruiting
- NCT06948916 — Validity and Reliability of 6-minute Pegboard and Ring Test in Patients With Interstitial Lung Disease · recruiting
- NCT06948942 — Exercise Capacity, Muscle Oxygenation, and Physical Activity Between Patients With Interstitial Lung Disease · recruiting
- NCT04611243 — Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19 · recruiting
Other Muğla Sıtkı Koçman University trials
Trials by the same sponsor.
- NCT05046834 — Effect of Cold Application on Patient's Pain and Vital Signs During Chest Tube Removal. · NA · withdrawn
- NCT07323160 — Determining the Effect of Education Given to Patients Undergoing Outpatient Anal Fistula Surgery · NA · not yet recruiting
- NCT07308730 — Pain Diary Use After Laparoscopic Cholecystectomy · NA · recruiting
- NCT06704399 — Psychoeducation Based on Acceptance and Commitment Therapy · NA · not yet recruiting
- NCT07183956 — Comparison of the Silverman-Andersen Score and the Downes Score · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04706650 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Muğla Sıtkı Koçman University
- Last refreshed: 13 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04706650.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing